Abeona Therapeutics Inc RPE

RPE von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Abeona Therapeutics Inc

Was macht Abeona Therapeutics Inc?

abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t

Unternehmen mit rpe ähnlich Abeona Therapeutics Inc

• Imperial Pacific International hat RPE von -HKD$428.57
• Indosolar hat RPE von -₨115.24
• Bluejay Mining Plc hat RPE von -£95.27
• Small Pharma Inc hat RPE von -CAD$89.38
• Treasury Metals hat RPE von -$82.14
• Treasury Metals hat RPE von -CAD$4.56
• Abeona Therapeutics Inc hat RPE von $0.00
• medical columbus AG hat RPE von €0.45
• Nyrstar NV hat RPE von €2.96
• Talon Metals hat RPE von CAD$10.55
• Highfield Resources hat RPE von AUD$12.94
• Venus Metals hat RPE von AUD$15.15
• Buderim hat RPE von AUD$54.64